Cardiology & Vascular Research

Cardiology & Vascular Research

Open Access
ISSN: 2639-8486
Research Article

Diabetes and Cannabis: Myth or Reality

Authors: María Luz Gunturiz Albarracín, Pablo Enrique Chaparro.

DOI: 10.33425/2639-8486.1008


Abstract

Medical marijuana is one of the fastest growing industries in the United States and in developing countries such as Colombia, but research into the benefits of the plant is a global issue. Although there are studies that present evidence that people who take or smoke it, may have a lower susceptibility to diabetes due to metabolic acceleration caused by the plant in the body, with this review we intend to show that the evidence obtained is not is still enough to think that marijuana could be a treatment for diabetes or other non-transmissible chronic diseases. This presumption is due to the lack of knowledge of its adverse effects and the consequences of cannabis use on the severity of these pathologies. Additionally, more clinical studies are required to demonstrate that marijuana activates the balance between metabolism and glucose and therefore demonstrate that this "medicinal" plant can help patients who already have the disease to decrease their dependence on insulin.

Whether or not cannabis use may increase or decrease the risk of diabetes is not completely clear.

View / Download PDF
Citation: María Luz Gunturiz Albarracín, Pablo Enrique Chaparro. Diabetes and Cannabis: Myth or Reality. 2018; 2(1). DOI: 10.33425/2639-8486.1008
Editor-in-Chief
Aris Lacis
Aris Lacis
Head of the Latvian State Cardiology Centre for Children | Head of the Clinic for Children Cardiology Latvia

View full editorial board →
Journal Metrics
Impact Factor 2.4*
Acceptance Rate 74.5%
Time to first decision 6-10 Days
Submission to acceptance 10-15 Days